For patients with asymptomatic severe aortic stenosis, transcatheter aortic valve replacement was superior to clinical ...

The U.S. Food and Drug Administration has approved Edwards Lifesciences' SAPIEN 3 platform, a transcatheter aortic valve replacement (TAVR) therapy, for patients with severe aortic stenosis without ...

This can be an important add-on to echocardiography in patients with a borderline need for intervention, researchers say.

DAVID MONTGOMERY: Aortic stenosis is a tightening of one of the four major valves of the heart. The aortic valve is particularly important because the aortic valve is the gateway to the rest of ...

If not done already, your doctor will order an echocardiogram to confirm the diagnosis of aortic stenosis. The test uses ...

University of East Anglia scientists have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before.

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be ...

“There is an urgent need to change practice and TAVR guidelines for the treatment of aortic stenosis patients, which currently recommend ‘watchful waiting’ until symptoms develop,” said ...

In the EARLY TAVR trial, which informed the approval, patients with asymptomatic severe aortic stenosis were randomly assigned to either TAVR or watchful waiting. During a median follow-up of 3.8 ...